The Effect of Systemic Chemotherapy on Neurogenesis, Plasticity and Memory
The DOI matches its Crossref record; its reference list is not available.
Abstract
Chemotherapy has been enormously successful in treating many forms of cancer and improving patient survival rates. With the increasing numbers of survivors, a number of cognitive side effects have become apparent. These have been called "chemobrain" or "chemofog" among patient groups, who describe the symptoms as a decline in memory, concentration and executive functions. Changes which, although subtle, can cause significant distress among patients and prevent a return to the quality of life experienced before treatment. This cognitive side effect of chemotherapy was not anticipated as it had been assumed that chemotherapy agents, administered systematically, could not cross the blood-brain barrier and that the brain was therefore protected from their action. It is now realised that low concentrations of many chemotherapy agents cross the blood-brain barrier and even those that are completely prevented from doing so, can induce the production of inflammatory cytokines in peripheral tissues which in turn can cross the blood-brain barrier and impact on the brain. A large number of patient studies have shown that cognitive decline is found in a proportion of patients treated with a variety of chemotherapy agents for different types of cancer. The deficits experienced by these patients can last for up to several years and have a deleterious effect on educational attainment and ability to return to work. Imaging studies of patients after systemic chemotherapy show that this treatm…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Humans receiving chemotherapy, which kills proliferating cells (thus blunting neurogenesis), experience cognitive deficits and are more likely to develop depression than cancer patients treated with other therapies128-130.”
From Dysregulation of adult hippocampal neuroplasticity in major depression: Pathogenesis and therapeutic implications (2022) · cites this paper as [129]
Citations
No citation lists for this paper
No citation lists for this paper yet — checked again daily.
References 225 · Cited by 66
Metadata
- Authors
- Wigmore, P.
- Affiliations
- Queen's Medical Centre (GB)
- Corresponding author
- Wigmore, Peter
- Venue
- Current Topics in Behavioral Neurosciences
- Publisher
- Springer Berlin Heidelberg
- Published
- 2012
- Volume
- 15
- Pages
- 211-240
- ISSN
- 1866-3370 (ISSN-L)
- 1866-3389
- OpenAlex
- W140248828
- Cited by
- 66
- References
- 225
- Citations by year
- 2026: 4 · 2025: 1 · 2024: 5 · 2023: 7 · 2022: 12 · 2021: 9 · 2020: 5 · 2019: 3 · 2018: 8 · 2017: 2 · 2016: 1 · 2015: 4 · 2014: 5
- FWCI
- 14.00
- Type
- book chapter
- Language
- en
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Current topics in behavioral neurosciences (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related cognitive impairment studies
- Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Intensive Care Unit Cognitive Disorders
- Keywords
- chemobrain, neurogenesis, neuroplasticity, memory, blood-brain barrier, peripheral inflammation, inflammatory cytokines, demyelination, hippocampal stem cells, oligodendrocyte precursor cells, cognitive behavioral therapy, cancer survivors
- MeSH terms
- Brain, Humans, Memory, Neuronal Plasticity, Neuroprotective Agents, Neurogenesis, Drug-Related Side Effects and Adverse Reactions
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Effect of Systemic Chemotherapy on Neurogenesis, Plasticity and Memory. https://app.cochat.ai/papers/10.1007/7854_2012_235
- The paper
- Wigmore, P. (2012). The Effect of Systemic Chemotherapy on Neurogenesis, Plasticity and Memory. Current Topics in Behavioral Neurosciences. https://doi.org/10.1007/7854_2012_235
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.